Share this article Share this article RYE BROOK, N.Y., March 8, 2021 /PRNewswire/ -- A new survey of more than 6,500 U.S. blood cancer patients and survivors reveals that only half are very likely to get a COVID-19 vaccine while one in three is either unlikely or unsure about it. The nationwide survey was a collaboration between The Leukemia & Lymphoma Society (LLS), Boston University Questrom School of Business and The Behaviouralist, a London-based research consultancy. The results come despite the serious risks facing blood cancer patients. Some early studies suggest around half of blood ...